Long-term changes in the personality and psychopathological profile of opiate addicts after nucleus accumbens ablative surgery are associated with treatment outcome

Stereotactic and Functional Neurosurgery

Volumn 91, Issue 1, 2013, Pages 30-44

  Ge, Shunnan ^a   Chang, Chongwang ^a   Adler, John R ^b   Zhao, Haikang ^a   Chang, Xiaozan ^a   Gao, Li ^a   Wu, Heming ^a   Wang, Jing ^a   Li, Nan ^a   Wang, Xuelian ^a   Gao, Guodong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nucleus accumbens; Opiate addiction; Personality; Psychopathology; Stereotactic neurosurgery

Indexed keywords

OPIATE;

ABLATION THERAPY; ADULT; AMNESIA; ARTICLE; BECK DEPRESSION INVENTORY; EYSENCK PERSONALITY QUESTIONNAIRE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PERSONALITY DISORDER; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PSYCHOMETRY; PSYCHOSIS; QUALITY OF LIFE; RELAPSE; STEREOTAXIC SURGERY; SYMPTOM CHECKLIST 90; TREATMENT OUTCOME; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; CATHETER ABLATION; FEMALE; HEROIN DEPENDENCE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MORPHINE; NEUROTIC DISORDERS; NUCLEUS ACCUMBENS; OLFACTION DISORDERS; PERSONALITY; PERSONALITY INVENTORY; PSYCHOSURGERY; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; SYMPTOM ASSESSMENT; TREATMENT OUTCOME;

EID: 84868688806     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000343199     Document Type: Article

References (53)

1. O'Brien CP, McLellan AT: Myths about the treatment of addiction. Lancet 1996; 347: 237-240
2. Kozlov AA, Rokhlina ML: 'Addictive' personality (in Russian). Zh Nevrol Psikhiatr Im S S Korsakova 2000; 100: 23-27
3. Darke S, Kaye S, Finlay-Jones R: Antisocial personality disorder, psychopathy and injecting heroin use. Drug Alcohol Depend 1998; 52: 63-69
4. Craig RJ: Prevalence of personality disorders among cocaine and heroin addicts. Subst Abus 2000; 21: 87-94
5. Rodriguez-Llera MC, Domingo-Salvany A, Brugal MT, Silva TC, Sanchez-Niubo A, Torrens M: Psychiatric comorbidity in young heroin users. Drug Alcohol Depend 2006; 84: 48-55
6. von Limbeek J, Wouters L, Kaplan CD, Geerlings PJ, von Alem V: Prevalence of psychopathology in drug-addicted Dutch. J Subst Abuse Treat 1992; 9: 43-52
7. Karow A, Verthein U, Krausz M, Schafer I: Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction. Eur Addict Res 2008; 14: 38-46
8. Carpentier PJ, Krabbe PF, van Gogh MT, Knapen LJ, Buitelaar JK, de Jong CA: Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict 2009; 18: 470-480
9. Tremeau F, Darreye A, Leroy B, Renckly V, Ertle S, Weibel H, Khidichian F, Macher JP: Personality changes in opioid-dependent subjects in a methadone maintenance treatment program (in French). Encephale 2003; 29: 285-292
10. Grusser SM, Thalemann CN, Platz W, Golz J, Partecke G: A new approach to preventing relapse in opiate addicts: a psychometric evaluation. Biol Psychol 2006; 71: 231-235
11. Ponizovsky AM, Margolis A, Heled L, Rosca P, Radomislensky I, Grinshpoon A: Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance. Subst Use Misuse 2010; 45: 288-313
12. Tang YL, Zhao D, Zhao C, Cubells JF: Opiate addiction in China: current situation and treatments. Addiction 2006; 101: 657-665
13. Lu L, Wang X, Kosten TR: Stereotactic neurosurgical treatment of drug addiction. Am J Drug Alcohol Abuse 2009; 35: 391-393
14. Kanaka TS, Balasubramaniam V: Stereotactic cingulumotomy for drug addiction. Appl Neurophysiol 1978; 41: 86-92
15. Balasubramaniam V, Kanaka TS, Ramanujam PB: Stereotaxic cingulumotomy for drug addiction. Neurol India 1973; 21: 63-66
16. Medvedev SV, Anichkov AD, Poliakov I: Physiological mechanisms of the effectiveness of bilateral stereotactic cingulotomy in treatment of strong psychological dependence in drug addiction (in Russian). Fiziol Cheloveka 2003; 29: 117-123
17. Gao G, Wang X, He S, Li W, Wang Q, Liang Q, Zhao Y, Hou F, Chen L, Li A: Clinical study for alleviating opiate drug psychological dependence by a method of ablating the nucleus accumbens with stereotactic surgery. Stereotact Funct Neurosurg 2003; 81: 96-104
18. Groenewegen HJ, Wright CI, Beijer AVJ: The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog Brain Res 1996; 107: 485-511
19. He F, Guan H, Zhao Z, Miao X, Zhou Q, Li L, Huang D, Liu A, Miao D: Evaluation of short-term psychological functions in opiate addicts after ablating the nucleus accumbens via stereotactic surgery. Stereotact Funct Neurosurg 2008; 86: 320-329
20. Gong Y: Handbook of Revised Version of Eysenck Personality Questionnaire (in Chinese). Changsha, Hunan Map Press, 1992
21. Eysenck HJ, Eysenck SB (eds): Eysenck Personality Questionnaire-Revised. San Diego, Educational and Industrial Testing Service, 1994
22. Center DB, Jackson N, Kemp D: A test of Eysenck's antisocial behavior hypothesis employing 11-to 15-year-old students dichotomous for PEN and L. Pers Individ Dif 2005; 38: 395-402
23. Roy A: Characteristics of drug addicts who attempt suicide. Psychiatry Res 2003; 121: 99-103
24. Zeng H: Coping styles and social support as well as personality characteristics of heroin addicts (in Chinese). Chin J Clin Rehabil 2005; 9: 100-101
25. Chen S, Li L: Re-testing reliability, validity and norm applicability of SCL-90 (in Chinese). Chin J Nerv Ment Dis 2003; 29: 323-327
26. Reimer J, Verthein U, Karow A, Schafer I, Naber D, Haasen C: Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction 2011; 106: 1647-1655
27. Wang L, Huang X, Kuang P, Qi W: Analysis of psychological states for 127 cases of heroin dependent addicts (in Chinese). Chin Bull Drug Depend 1996; 5: 238-241
28. Skevington SM, Lotfy M, O'Connell KA: The world health organization's WHOQOLBREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004; 13: 299-310
29. Yen C, Wang C, Wang T, Chen H, Chang H: Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci 2011; 27: 177-183
30. Fang J, Hao Y, Li C: Reliability and validity for Chinese version of WHO quality of life scale (in Chinese). Chin Ment Health J 1999; 13: 203-205
31. Beck AT, Steer RA: Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984; 40: 1365-1367
32. Min Z, Xu L, Chen H, Ding X, Yi Z, Zhang M: A pilot assessment of relapse prevention for heroin addicts in a Chinese rehabilitation center. Am J Drug Alcohol Abuse 2011; 37: 141-147
33. Woody SR, Steketee G, Chambless DL: Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale. Behav Res Ther 1995; 33: 597-605
34. Hariz MI, Hirabayashi H: Is there a relationship between size and site of the stereotactic lesion and symptomatic results of pallidotomy and thalamotomy? Stereotact Funct Neurosurg 1997; 69: 28-45
35. Lecca ED, Piras G, Driscoll P, Giorgi O, Corda MG: A differential activation of dopamine output in the shell and core of the nucleus accumbens is associated with the motor responses to addictive drugs: a brain dialysis study in Roman high-and lowavoidance rats. Neuropharmacology 2004; 46: 688-699
36. Pontieri FE, Tanda G, Di Chiara G: Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc Natl Acad Sci USA 1995; 92: 12304-12308
37. Koob GF: Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992; 13: 177-184
38. Lu L, Shepard JD, Hall FS, Shaham Y: Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 2003; 27: 457-491
39. Johansson F, Malm J, Nordh E, Mariz M: The usefulness of pallidotomy in advanced Parkinson's disease. J Neurosurg Neurol Psychiatr 1997; 62: 125-132
40. Hariz MI: Correlation between clinical outcome and size and site of the lesion in CTguided thalamotomy and pallidotomy. Stereotact Funct Neurosurg 1990; 54/55: 172-185
41. Sarramon C, Verdoux H, Schmitt L, Bourgeois M: Addiction and personality traits: sensation seeking, anhedonia, impulsivity. Encephale 1999; 25: 569-575
42. Knyazev GG: Behavioural activation as predictor of substance use: mediating and moderating role of attitudes and social relationships. Drug Alcohol Depend 2004; 75: 309-321
43. Steer RA, Platt JJ, Hendriks VM, Metzger DS: Types of self-reported psychopathology in Dutch and American heroin addicts. Drug Alcohol Depend 1989; 24: 175-181
44. Hendriks VM, Steer RA, Platt JJ, Metzger DS: Psychopathology in Dutch and American heroin addicts. Int J Addict 1990; 25: 1051-1063
45. Nicola SM: The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl) 2007; 191: 521-550
46. Del AA, Mora F: Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 2009; 116: 941-952
47. Mikell CB, McKhann GM, Segal S, McGovern RA, Wallenstein MB, Moore H: The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact Funct Neurosurg 2009; 87: 256-265
48. Franzini A, Messina G, Gambini O, Muffatti R, Scarone S, Cordella R, Broggi G: Deepbrain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci 2010; 31: 353-359
49. Bewernick BH, Kayser S, Sturm V, Schlaepfer TE: Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012; 37: 1975-1985
50. McLellan AT, Lewis DC, O'Brien CP, Kleber HD: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689-1695
51. Ryan CF, White JM: Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996; 91: 39-45
52. Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, Magri N, Martin S, Vazquez JM: Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse 2004; 39: 1353-1368
53. Li Q, Wang Y, Cui G, Xiong X, Yang L, Li Y, Wang W: Volume measurement of nucleus accumbens in healthy adults by MR: an initial study (in Chinese). Radiol Practice 2009; 24: 825-827.